Baidu
map

原发性线粒体肌病的治疗:REN001获得FDA孤儿药称号

2020-06-24 Allan MedSci原创

Reneo Pharmaceuticals今日宣布,美国食品药品监督管理局(FDA)已授予该公司的主要候选药物REN001治疗原发性线粒体肌病(PMM)的孤儿药称号。

Reneo Pharmaceuticals今日宣布,美国食品药品监督管理局(FDA)已授予该公司的主要候选药物REN001治疗原发性线粒体肌病(PMM)的孤儿药称号。该公司还宣布了最近完成的针对PMM患者的REN001临床研究的积极结果。

REN001是一款选择性PPARδ激动剂,可治疗包括PMM在内的遗传性肌病。PMM是线粒体基因突变所致的严重疾病,PMM患者的肌肉功能通常会下降,对日常功能产生不利影响,并且患者寿命会缩短。目前尚无FDA批准的用于治疗PMM的药物。

Reneo Pharmaceuticals首席执行官Niall O’Donnell博士说:“患有线粒体原发性肌病的患者的生活受到很多方面的影响”。Reneo对患有线粒体基因缺陷和肌病史的PMM患者完成了为期12周的临床试验(REN001研究)。患者每天口服一次REN001,大多数患者选择参加另外的36周开放标签延伸研究。REN001研究考察了步行测试和一些症状问卷的结果,该研究的安全性数据表明,REN001在PMM患者中是安全的且耐受性良好。

 

原始出处:

https://www.firstwordpharma.com/node/1735037?tsid=4

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1946483, encodeId=974a194648363, content=<a href='/topic/show?id=309a3e08777' target=_blank style='color:#2F92EE;'>#原发性线粒体肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37087, encryptionId=309a3e08777, topicName=原发性线粒体肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Thu Feb 11 14:26:57 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846901, encodeId=bb0c1846901a1, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jul 30 02:26:57 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365237, encodeId=bbf5136523e1f, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45434, encryptionId=dfa045434e1, topicName=孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd0d217, createdName=huiwelcome, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7303, encryptionId=72fee303d6, topicName=FDA孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebe466, createdName=mxj1971612, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622452, encodeId=b7cd1622452cb, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1946483, encodeId=974a194648363, content=<a href='/topic/show?id=309a3e08777' target=_blank style='color:#2F92EE;'>#原发性线粒体肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37087, encryptionId=309a3e08777, topicName=原发性线粒体肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Thu Feb 11 14:26:57 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846901, encodeId=bb0c1846901a1, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jul 30 02:26:57 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365237, encodeId=bbf5136523e1f, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45434, encryptionId=dfa045434e1, topicName=孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd0d217, createdName=huiwelcome, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7303, encryptionId=72fee303d6, topicName=FDA孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebe466, createdName=mxj1971612, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622452, encodeId=b7cd1622452cb, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1946483, encodeId=974a194648363, content=<a href='/topic/show?id=309a3e08777' target=_blank style='color:#2F92EE;'>#原发性线粒体肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37087, encryptionId=309a3e08777, topicName=原发性线粒体肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Thu Feb 11 14:26:57 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846901, encodeId=bb0c1846901a1, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jul 30 02:26:57 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365237, encodeId=bbf5136523e1f, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45434, encryptionId=dfa045434e1, topicName=孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd0d217, createdName=huiwelcome, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7303, encryptionId=72fee303d6, topicName=FDA孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebe466, createdName=mxj1971612, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622452, encodeId=b7cd1622452cb, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1946483, encodeId=974a194648363, content=<a href='/topic/show?id=309a3e08777' target=_blank style='color:#2F92EE;'>#原发性线粒体肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37087, encryptionId=309a3e08777, topicName=原发性线粒体肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Thu Feb 11 14:26:57 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846901, encodeId=bb0c1846901a1, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jul 30 02:26:57 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365237, encodeId=bbf5136523e1f, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45434, encryptionId=dfa045434e1, topicName=孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd0d217, createdName=huiwelcome, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7303, encryptionId=72fee303d6, topicName=FDA孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebe466, createdName=mxj1971612, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622452, encodeId=b7cd1622452cb, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1946483, encodeId=974a194648363, content=<a href='/topic/show?id=309a3e08777' target=_blank style='color:#2F92EE;'>#原发性线粒体肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37087, encryptionId=309a3e08777, topicName=原发性线粒体肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951d2500061, createdName=12498717m66(暂无昵称), createdTime=Thu Feb 11 14:26:57 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846901, encodeId=bb0c1846901a1, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Jul 30 02:26:57 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365237, encodeId=bbf5136523e1f, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45434, encryptionId=dfa045434e1, topicName=孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd0d217, createdName=huiwelcome, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7303, encryptionId=72fee303d6, topicName=FDA孤儿药称号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebe466, createdName=mxj1971612, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622452, encodeId=b7cd1622452cb, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jun 26 09:26:57 CST 2020, time=2020-06-26, status=1, ipAttribution=)]

相关资讯

Neurology:Elamipretide可大幅改善原发性线粒体肌病患者运动能力

研究认为,Elamipretide可提高原发性线粒体肌病患者的运动能力,无明显毒副作用

拓展阅读

Neurology:Elamipretide可大幅改善原发性线粒体肌病患者运动能力

研究认为,Elamipretide可提高原发性线粒体肌病患者的运动能力,无明显毒副作用

Baidu
map
Baidu
map
Baidu
map